Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipientsCARTER, J. T; MELCHER, M. L; CARLSON, L. L et al.American journal of transplantation (Print). 2006, Vol 6, Num 4, pp 753-760, issn 1600-6135, 8 p.Article

Virologic and Clinical Outcomes of Hepatitis B Virus Infection in HIV-HBV Coinfected Transplant RecipientsCOFFIN, C. S; STOCK, P. G; TERRAULT, N. A et al.American journal of transplantation (Print). 2010, Vol 10, Num 5, pp 1268-1275, issn 1600-6135, 8 p.Article

Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipientsFRASSETTO, L. A; BROWNE, M; CHENG, A et al.American journal of transplantation (Print). 2007, Vol 7, Num 12, pp 2816-2820, issn 1600-6135, 5 p.Article

Reduction of HIV Persistence Following Transplantation in HIV-Infected Kidney Transplant RecipientsSTOCK, P. G; BARIN, B; HATANO, H et al.American journal of transplantation (Print). 2014, Vol 14, Num 5, pp 1136-1141, issn 1600-6135, 6 p.Article

HIV-Infected Liver and Kidney Transplant Recipients: 1-and 3-Year OutcomesROLAND, M. E; BARIN, B; MURPHY, B et al.American journal of transplantation (Print). 2008, Vol 8, Num 2, pp 355-365, issn 1600-6135, 11 p.Article